Ontex’s 2025 annual report, published in March 2026, describes the reorganisation of its Belgian operations. It discusses the closure of Eeklo and the role of Buggenhout as a research, development and manufacturing centre.
The Buggenhout role specifically covers products for moderate and heavy incontinence. The report therefore documents a change in the company’s adult-care development and production network.
This is a company report on its reorganisation, rather than line-by-line commissioning evidence. It does not establish that every staffing or associated-cost process is complete, or give verified capacity for each adult-product line. The exact publication day has not been identified.